Congenital syphilis laboratory findings: Difference between revisions

Jump to navigation Jump to search
Kalsang Dolma (talk | contribs)
Kalsang Dolma (talk | contribs)
No edit summary
Line 2: Line 2:
{{CMG}} {{AE}} {{KD}}
{{CMG}} {{AE}} {{KD}}
{{Congenital syphilis}}
{{Congenital syphilis}}
==Overview==
==Laboratory Findings==
==Laboratory Findings==



Revision as of 20:32, 4 December 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Congenital infections Main Page

Congenital syphilis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Congenital Syphilis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Congenital syphilis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Congenital syphilis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congenital syphilis laboratory findings

CDC on Congenital syphilis laboratory findings

Congenital syphilis laboratory findings in the news

Blogs on Congenital syphilis laboratory findings

Directions to Hospitals Treating Congenital syphilis

Risk calculators and risk factors for Congenital syphilis laboratory findings

Laboratory Findings

Serology

The diagnosis of congenital syphilis is complicated by the transplacental transfer of maternal nontreponemal and tre-ponemal IgG antibodies to the fetus. This transfer of antibodies makes the interpretation of reactive serologic tests for syphilis in infants difficult.

All infants born to mothers who have reactive nontreponemal and treponemal test results should be evaluated with a quantitative nontreponemal serologic test (RPR or VDRL) performed on infant serum because umbilical cord blood can become contaminated with maternal blood and could yield a false-positive result. Conducting a treponemal test (i.e., TP-PA or FTA-ABS) on a newborn’s serum is not necessary. No commercially available immunoglobulin (IgM) test can be recommended.

Dark Microscopic Examination

All infants born to women who have reactive serologic tests for syphilis should be examined thoroughly for evidence of congenital syphilis (e.g., nonimmune hydrops, jaundice, hepatosplenomegaly, rhinitis, skin rash, and/or pseudoparalysis of an extremity). Pathologic examination of the placenta or umbilical cord by using specific fluorescent antitreponemal antibody staining is suggested. Darkfield microscopic examination or DFA staining of suspicious lesions or body fluids (e.g., nasal discharge) also should be performed.

CSF Analysis for VDRL, Cell count, and Protein

Complete Blood Count (CBC) and Differential and Platelet count

References

Template:WikiDoc Sources